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Corrigendum
Celecoxib and acetylbritannilactone interact
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Correction to: Cell Death and Disease (2011) 2, e185;
Published online 28 July 2011; doi:10.1038/cddis.2011.64
Since the publication of the article, the Authors and Editors
have determined that Figure 3a was incorrect. The ﬁgure
below is the correct version.
The authors would like to apologize for this error.
Figure3 EffectsofthecombinationofcelecoxibandABLonCOX-2expressionandactivityinMDA-MD-231cells.(a)MDA-MD-231cellsweretreatedwithcelecoxib,ABL
or their combination for 24h (left) or 48h (right). COX-2 mRNA and protein expression was examined using RT-PCR (left) and western blot analysis (right). Quantiﬁcation of
COX-2 mRNA and protein expression normalized to actin levels, were provided at the bottom. (b) MDA-MB-231 cells were treated with the combination for 48h, and PGE2
levels in the culture medium were measured using ELISA. Results were expressed as mean±S.E.M. from at least three independent experiments
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